During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.

More promising news in the treatment of alopecia areata. More clinical trials are needed to ensure safety and efficacy but very promising.

This analysis demonstrates that there is no increased risk of cancer when using spironolactone.

For some highly motivated patients, a combination of two therapies can be effective in helping hair loss.

The New England Journal of Medicine published an interesting article on vaccine effectiveness and the need for boosters.

The attached article from the FDA outlines the medical risks associated with JAK(Janus kinase) inhibitors for the treatment of alopecia totalis and universalis.